|Articles|July 1, 2002
Eye drops delay onset of glaucoma
Author(s)Lynda Charters
Bethesda, MD-Glaucoma management has entered a new era. Based on the results of the long-awaited Ocular Hypertension Treatment Study (OHTS), physicians now have clear guidelines for treating patients at high risk for developing glaucoma that may actually prevent the disease.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
FDA approves veligrotug-vvze (Lumvoa) for thyroid eye disease across active and chronic stages
2
Detecting peripheral retinal lesions in children with myopia
3
4DMT completes enrollment in 4FRONT-2, global phase 3 trial of 4D-150 in wet AMD
4
FDA grants priority review to Satralizumab sBLA for thyroid eye disease
5






















